12:00 AM
 | 
Feb 18, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Promus Premier Everolimus-Eluting Platinum Chromium Coronary Stent System regulatory update

Boston Scientific said it received CE Mark approval for its Promus Premier Everolimus-Eluting Platinum Chromium Coronary Stent System for coronary artery...

Read the full 82 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >